Table 3.
Formula | Emulsification time (s) | Mean droplet size (nm) | Zeta potential (mV) | Q5 | Q60 | %DE |
---|---|---|---|---|---|---|
F3 | 20±1.3 | 440±9.9 | −9.73±0.16 | 76±1.6 | 88.0±2.1 | 86.5 |
F4 | 17±0.5 | 285±2.6 | −13.7±0.2 | 90±2.4 | 95.2±1.1 | 89.6 |
F5 | 20±1.1 | 404±5.6 | −8.76±0.12 | 75±2.1 | 90.7±2.0 | 76.7 |
F6 | 20±0.9 | 420±4.9 | −5.7±0.1 | 80±1.7 | 88.7±1.8 | 80.7 |
F7 | 29±1.3 | 459±5.5 | −5.45±0.3 | 78±2.3 | 88.2±0.9 | 81.0 |
F8 | 34±1.7 | 477±1.07 | −5.18±0.2 | 87±2.0 | 95.3±0.8 | 90.1 |
F9 | 17±1.5 | 471±3.6 | −6.84±0.1 | 83±1.9 | 96.0±1.7 | 86.9 |
F19* | 27±0.8 | 336±11.6 | −15.4±0.6 | 94±1.1 | 100±0.6 | 95.5 |
F20 | 23±0.6 | 380±5.6 | −11.9±0.2 | 79±2.2 | 95.5±2.1 | 88.1 |
F21 | 32±1.3 | 423±4.4 | −8.6±0.03 | 78±0.9 | 94.0±1.7 | 85.4 |
F26 | 75±3.2 | 823±3.2 | −3.7±0.5 | 77±3.1 | 85.0±2.8 | 82.5 |
F27 | 99±2.7 | 775±6.2 | −2.2±0.4 | 73±2.5 | 78.7±2.3 | 73.5 |
Pure drug | NA | NA | NA | 19±1.3 | 55±2.2 | 42.5 |
Notes: Data are presented as mean ± standard deviation.
F19 is the optimal formula that was selected for in vivo studies.
Abbreviation: NA, not applied.